<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>300</height>
  <width>600</width>
  <title>FDA Approves Axsome’s New Migraine Drug Symbravo®</title>
  <description>The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O’Brien has the details and when it becomes available in this Migraine Minute News update.&amp;amp;nbsp; &amp;amp;nbsp; Learn More:  https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam </description>
  <author_name>Migraine Minute News Update</author_name>
  <author_url>http://migraineminute.libsyn.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/35952450/height/300/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/256d9f/" height="300" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/35952450</thumbnail_url>
</oembed>
